Naomi: a new modelling tool for estimating HIV epidemic indicators at the district level in sub‐Saharan Africa
Open Access
- 21 September 2021
- journal article
- research article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 24 (S5) , e25788
Abstract
Introduction: HIV planning requires granular estimates for the number of people living with HIV (PLHIV), antiretroviral treatment (ART) coverage and unmet need, and new HIV infections by district, or equivalent subnational administrative level. We developed a Bayesian small‐area estimation model, called Naomi, to estimate these quantities stratified by subnational administrative units, sex, and five‐year age groups.Methods: Small‐area regressions for HIV prevalence, ART coverage and HIV incidence were jointly calibrated using subnational household survey data on all three indicators, routine antenatal service delivery data on HIV prevalence and ART coverage among pregnant women, and service delivery data on the number of PLHIV receiving ART. Incidence was modelled by district‐level HIV prevalence and ART coverage. Model outputs of counts and rates for each indicator were aggregated to multiple geographic and demographic stratifications of interest. The model was estimated in an empirical Bayes framework, furnishing probabilistic uncertainty ranges for all output indicators. Example results were presented using data from Malawi during 2016–2018.Results: Adult HIV prevalence in September 2018 ranged from 3.2% to 17.1% across Malawi's districts and was higher in southern districts and in metropolitan areas. ART coverage was more homogenous, ranging from 75% to 82%. The largest number of PLHIV was among ages 35 to 39 for both women and men, while the most untreated PLHIV were among ages 25 to 29 for women and 30 to 34 for men. Relative uncertainty was larger for the untreated PLHIV than the number on ART or total PLHIV. Among clients receiving ART at facilities in Lilongwe city, an estimated 71% (95% CI, 61% to 79%) resided in Lilongwe city, 20% (14% to 27%) in Lilongwe district outside the metropolis, and 9% (6% to 12%) in neighbouring Dowa district. Thirty‐eight percent (26% to 50%) of Lilongwe rural residents and 39% (27% to 50%) of Dowa residents received treatment at facilities in Lilongwe city.Conclusions: The Naomi model synthesizes multiple subnational data sources to furnish estimates of key indicators for HIV programme planning, resource allocation, and target setting. Further model development to meet evolving HIV policy priorities and programme need should be accompanied by continued strengthening and understanding of routine health system data.Keywords
Funding Information
- Joint United Nations Programme on HIV/AIDS
- Bill and Melinda Gates Foundation (OPP1190661, OPP1191665)
- National Institute of Allergy and Infectious Diseases (R01AI029168, R01AI136664, R03AI125001)
- Medical Research Council (MR/R015600/1)
This publication has 30 references indexed in Scilit:
- Statistical models for incorporating data from routine HIV testing of pregnant women at antenatal clinics into HIV/AIDS epidemic estimatesAIDS, 2017
- Scaling-up antiretroviral therapy in MalawiBulletin of the World Health Organization, 2016
- Evaluation of geospatial methods to generate subnational HIV prevalence estimates for local level planningAIDS, 2016
- TMB: Automatic Differentiation and Laplace ApproximationJournal of Statistical Software, 2016
- People living with HIV travel farther to access healthcare: a population‐based geographic analysis from rural UgandaJournal of the International AIDS Society, 2016
- Mapping HIV prevalence using population and antenatal sentinel-based HIV surveys: a multi-stage approachPopulation Health Metrics, 2015
- HIV estimates at second subnational level from national population-based surveysAIDS, 2014
- A New General Biomarker-based Incidence EstimatorEpidemiology, 2012
- Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi2006
- Estimating the size of hard-to-reach populations: a novel method using HIV testing data compared to other methodsAIDS, 2001